Clinical Trial

EUS-Guided ATI and SWE in Individuals With Normal FibroScan

Study acronym: EUS ATI&SWE
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to establish preliminary reference values for Endoscopic Ultrasound (EUS)-guided Attenuation Imaging (ATI) and Shear Wave Elastography (SWE) in adults undergoing diagnostic EUS for non-hepatobiliary indications who have normal FibroScan findings. The main questions it aims to answer are: What are the preliminary normal reference values for EUS-guided ATI in the right and left hepatic lobes? What are the preliminary normal reference values for EUS-guided SWE elasticity (kPa) and velocity (m/s) in the right and left hepatic lobes? Participants will: Undergo same-day FibroScan assessment to confirm normal liver stiffness and steatosis parameters. Undergo EUS-guided ATI and SWE measurements of both the right and left hepatic lobes during their clinically indicated diagnostic EUS examination. Have demographic, clinical, and laboratory information recorded for analysis.
Trial Details
NCT Number NCT07714941
Lead Sponsor Asian Institute of Gastroenterology, India
Conditions Non-hepatobiliary Indications
Enrollment 100 participants
Start Date 2026-08-20
Primary Completion 2027-08-30 (estimated)
Study Completion 2027-09-20 (estimated)
Updated on ClinicalTrials.gov 2026-07-20